FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid (This Dec.20 story corrects first paragraph to say the approval came four months ahead of schedule, not three months, after FDA clarification) (Reuters) – The U.S.… Read More »
The House has passed a bill to lower the price of prescription medications by allowing Medicare to negotiate prices with pharmaceutical companies, but the bill is expected to get nowhere in the Senate. House Speaker Nancy Pelosi’s Lower Drug Costs Now Act of 2019 passed by a vote of 230-192 Thursday, largely along party lines.… Read More »
Dec. 13, 2019 — A U.S. House Democrat bill that would give Medicare the authority to negotiate prescription drug prices and provide new benefits for seniors was passed Thursday in a 230-192 vote along party lines. However, the bill has no chance of being passed by the Republican-controlled Senate and the White House has threatened… Read More »
SNRIs are associated with less side effects and some people like them better because they address the possibility that low norepinephrine causes depression or can be as important as serotonin in what drug class is cymbalta in cases. But if that doesn’t work, here are six other hacks to try. The dual transporter inhibitor duloxetine:… Read More »